tiprankstipranks
Trending News
More News >
Ultragenyx Pharmaceutical (RARE)
NASDAQ:RARE

Compare Ultragenyx Pharmaceutical (RARE) vs. Competitors

Compare
1,178 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Ultragenyx Pharmaceutical
$23.50
$2.32B
-3.96
-42.65%
17 Buy
1 Hold
0 Sell
Strong Buy
Travere Therapeutics
$28.40
$2.59B
-26.18
57.17%
11 Buy
2 Hold
0 Sell
Strong Buy
Xenon
$41.58
$3.21B
-10.49
1.52%
14 Buy
0 Hold
0 Sell
Strong Buy
Disc Medicine
$71.04
$2.91B
-13.26
17.48%
13 Buy
0 Hold
0 Sell
Strong Buy
Tarsus Pharmaceuticals
$75.23
$3.19B
-36.58
58.18%
6 Buy
1 Hold
0 Sell
Strong Buy
Mineralys Therapeutics, Inc.
$33.42
$2.64B
-10.61
219.23%
6 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
RARE
Ultragenyx Pharmaceutical
23.50
-17.35
-42.47%
TVTX
Travere Therapeutics
28.40
9.93
53.76%
XENE
Xenon
40.74
1.12
2.83%
IRON
Disc Medicine
71.04
11.09
18.50%
TARS
Tarsus Pharmaceuticals
73.65
26.73
56.97%
MLYS
Mineralys Therapeutics, Inc.
31.38
21.88
230.32%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts